Drug Approval | March 19, 2024
Carbogen Amcis (Shanghai) completed ANVISA Audit
A five-day inspection was concluded successfully with no critical and no major observations raised
A five-day inspection was concluded successfully with no critical and no major observations raised
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
The drug will target specific genetic mutations prevalent in certain types of cancers
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
It is the first autotaxin inhibitor to be investigated in cancer patients
Subscribe To Our Newsletter & Stay Updated
